Chimera Investment Corp
NYSE:CIM
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
11.37
17.7097
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
Abbvie Inc
NYSE:ABBV
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Realty Income Corp
NYSE:O
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
Chimera Investment Corp. operates as a real estate investment trust. [ Read More ]
The intrinsic value of one CIM stock under the Base Case scenario is 35.61 USD. Compared to the current market price of 14.99 USD, Chimera Investment Corp is Undervalued by 58%.
Valuation Backtest
Chimera Investment Corp
Run backtest to discover the historical profit from buying and selling CIM stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Chimera Investment Corp
Current Assets | 250.1m |
Cash & Short-Term Investments | 169m |
Receivables | 81.1m |
Non-Current Assets | 12.3B |
Long-Term Investments | 1.2B |
Other Non-Current Assets | 11.1B |
Current Liabilities | 2.5B |
Accounts Payable | 16.5m |
Accrued Liabilities | 35.5m |
Short-Term Debt | 2.4B |
Other Current Liabilities | 54.8m |
Non-Current Liabilities | 7.4B |
Long-Term Debt | 7.4B |
Earnings Waterfall
Chimera Investment Corp
Revenue
|
740.5m
USD
|
Cost of Revenue
|
-543.3m
USD
|
Gross Profit
|
197.2m
USD
|
Operating Expenses
|
-73m
USD
|
Operating Income
|
124.2m
USD
|
Other Expenses
|
242k
USD
|
Net Income
|
124.4m
USD
|
Free Cash Flow Analysis
Chimera Investment Corp
USD | |
Free Cash Flow | USD |
CIM Profitability Score
Profitability Due Diligence
Chimera Investment Corp's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
Score
Chimera Investment Corp's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
CIM Solvency Score
Solvency Due Diligence
Chimera Investment Corp's solvency score is 9/100. The higher the solvency score, the more solvent the company is.
Score
Chimera Investment Corp's solvency score is 9/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CIM Price Targets Summary
Chimera Investment Corp
According to Wall Street analysts, the average 1-year price target for CIM is 14.92 USD with a low forecast of 14.39 USD and a high forecast of 15.75 USD.
Ownership
CIM Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Price Appreciation
CIM Price
Chimera Investment Corp
Average Annual Return | -4.55% |
Standard Deviation of Annual Returns | 58.22% |
Max Drawdown | -72% |
Market Capitalization | 1.2B USD |
Shares Outstanding | 80 473 000 |
Percentage of Shares Shorted | 2.35% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Chimera Investment Corp. operates as a real estate investment trust. The company is headquartered in New York City, New York and currently employs 38 full-time employees. The company went IPO on 2007-11-16. The firm invests in residential mortgage loans through secondary market purchases from banks, non-bank financial institutions, and the agencies. These mortgage loans are secured primarily by residential properties in the United States. The company also invests in investment grade, non-investment grade and non-rated non-agency RMBS. The firm is focused on investing in commercial mortgage loans consisting of first or second lien loans secured by multifamily properties. The company is also focused on investing in securities issued in various collateralized debt obligation (CDO).
Contact
IPO
Employees
Officers
The intrinsic value of one CIM stock under the Base Case scenario is 35.61 USD.
Compared to the current market price of 14.99 USD, Chimera Investment Corp is Undervalued by 58%.